The effects of deep neuromuscular block on surgical technique and perioperative patients' conditions in patients undergoing spine surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001264

Enrollment

Registered

2014-10-27

Start date

2014-10-27

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Deep neuromuscular block group - Rocuronium 5-7ug/kg/min continuous infusion to maintain the post-tetanic count 1-2 by using train of four device Moderate neuromuscular block group - Rocuroni

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing spinal fusion surgery in Konkuk University Medical Center and agreed to participate this study

Exclusion criteria

Exclusion criteria: 1. American society of anesthesiologist classification > 3 2. Age < 19, > 80 3. Patients diagnosed neuromuscular disorder 4. Allergy to neuromuscular blocking agents or anesthesic agents 5. Family history of malignant hyperthermia 6. Decreased renal function (Serem creatine over twice than normal range, urine output < 0.5 ml/kg/hr, Glomerular filtration ratio < 60 ml/hr) 7. Previous spine surgery

Design outcomes

Primary

Measure	Time frame
surgical bleeding	—

Secondary

Measure	Time frame
mean arterial blood pressure;heart rate;central venous pressure;cardiac index;stroke volume variation;amount of neuromuscular blocking agent;post-operative pain;bleeding for 24 hours after surgical procedure	—

Countries

Korea, Republic of

Contacts

Public ContactWoon-Seok Kang

Konkuk University Medical Center

Outcome results